drugset / Trial / NCT00733122
Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This study is designed to determine the tolerability and immunogenicity of a 3-dose regimen of Gardasil administered to healthy married females between 16 and 23 years of age, in India.
Timeline
- Start
- 2009-10-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gardasil | Vaccine | 0.5 ml | Intramuscular |